A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03057171 |
Recruitment Status :
Recruiting
First Posted : February 17, 2017
Last Update Posted : March 18, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Helicobacter Pylori Infection Gastric Ulcer Duodenal Ulcer Stomach Cancer |
Study Type : | Observational |
Estimated Enrollment : | 50 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA |
Actual Study Start Date : | May 2015 |
Estimated Primary Completion Date : | April 2020 |
Estimated Study Completion Date : | April 2020 |

Group/Cohort |
---|
Gastric ulcer
patients who will undergo EGD for gastric ulcer
|
Duodenal ulcer
patients who will undergo EGD for duodenal ulcer
|
Stomach cancer
patients who will undergo EGD for stomach cance
|
health individuals
patients who will undergo screening EGD
|
- Expression of THRIL, PACER [ Time Frame: Within 2 weeks after EGD ]Expression of THRIL, PACER according to Helicobacter pylori infection by Real-time aRT-PCR
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Over 19 years old
- Patients with gastric ulcer
- Patients with duodenal ulcer
- Patients with stomach cancer
- Patients with gastrointestinal discomfort symptoms
Exclusion Criteria:
- Patients who has done helicobacter pylori eradication
- Patients who has undergone gastrectomy
- Patients who has undergone endoscopic submucosal dissection
- Patients with active upper gastrointestinal bleeding

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03057171
Contact: Sang Kil Lee, MD | 82-2-2228-1996 | sklee@yuhs.ac |
Korea, Republic of | |
Yonsei university College of Medicine | Recruiting |
Seoul, Korea, Republic of, 03722 | |
Contact: Sang Kil Lee, MD 82-2-2228-1996 sklee@yuhs.ac |
Responsible Party: | Yonsei University |
ClinicalTrials.gov Identifier: | NCT03057171 |
Other Study ID Numbers: |
4-2015-0146 |
First Posted: | February 17, 2017 Key Record Dates |
Last Update Posted: | March 18, 2019 |
Last Verified: | March 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Helicobacter pylori long non-coding RNA THRIL PACER cagA |
Stomach Neoplasms Gastrointestinal Diseases Digestive System Diseases Stomach Ulcer Duodenal Ulcer Ulcer Pathologic Processes Gastrointestinal Neoplasms |
Digestive System Neoplasms Neoplasms by Site Neoplasms Stomach Diseases Peptic Ulcer Duodenal Diseases Intestinal Diseases |